Mario Ojeda‐Uribe
Mario Ojeda‐Uribe publishes mostly in Hematology, Genetics and Immunology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #2,257,266 of 7,710,434 ranked researchers
- Rank in France
- #97,180 of 324,115
- Works
- 107
- Citations
- 2k
- Citations per work
- 18.3
What does Mario Ojeda‐Uribe research?
Mario Ojeda‐Uribe's work is mostly in Medicine (54%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5753.5%
- Medicine5753.5%
- Everything else3532.3%
- Life Sciences1514.2%
- 1Hematology30% of their works
- 2Genetics12% of their works
- 3Immunology8% of their works
- 4Oncology8% of their works
- 5Molecular Biology6% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
Which keywords describe Mario Ojeda‐Uribe's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Minimal Residual Disease, BCR-ABL, Imatinib and JAK2 Mutation.
- Diagnosis Criteria
- Complement
- Acute Lymphoblastic Leukemia
- Classification
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- BCR-ABL
- Rituximab
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Minimal Residual Disease
- Imatinib
- Myelofibrosis
- Genomic Aberrations
- Lymphoma
- Childhood Cancer
- Immune
- International Myeloma Working Group
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors623 topics
- AML361 topic
- Acute Myeloid Leukemia361 topic
- Rituximab272 topics
- Minimal Residual Disease222 topics
- BCR-ABL191 topic
- Imatinib191 topic
- JAK2 Mutation161 topic
- Myelofibrosis161 topic
- Chronic Lymphocytic Leukemia141 topic
- Genomic Aberrations141 topic
- Classification131 topic
- Lymphoma131 topic
- Acute Lymphoblastic Leukemia121 topic
- Childhood Cancer121 topic
- Complement111 topic
- Immune111 topic
- Diagnosis Criteria101 topic
- International Myeloma Working Group101 topic
Where does Mario Ojeda‐Uribe work?
Mario Ojeda‐Uribe's main affiliation in the publication record is Centre Hospitalier de Mulhouse, France.
How many publications and citations does Mario Ojeda‐Uribe have?
OpenAlex counts 107 works and 1,953 citations for Mario Ojeda‐Uribe, an h-index of 22, ranking #2,257,266 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mario Ojeda‐Uribe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.